Jiangxi Fushine Pharmaceutical Co., Ltd. (SHE:300497)
China · Delayed Price · Currency is CNY 20.02
+0.04 (0.20%)
Sep 11, 2026, 3:04 PM CST
SHE:300497 Market Cap
SHE:300497 has a market cap or net worth of 10.78 billion as of September 11, 2026. Its market cap has increased by 93.06% in one year.
Market Cap
10.78B
Enterprise Value
11.91B
Revenue
1.56B
Ranking
n/a
PE Ratio
73.47
Stock Price
20.02
ChartMarket Cap Chart
Since December 22, 2015, SHE:300497's market cap has increased from 1.59B to 10.78B, an increase of 578.33%. That is a compound annual growth rate of 19.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 10.78B | 32.50% |
| Dec 31, 2025 | 8.14B | 81.18% |
| Dec 31, 2024 | 4.49B | -10.90% |
| Dec 29, 2023 | 5.04B | -29.09% |
| Dec 30, 2022 | 7.11B | -19.99% |
| Dec 31, 2021 | 8.89B | 34.93% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chengzhi | 11.50B |
| Tibet Cheezheng Tibetan Medicine | 11.46B |
| Chengdu Olymvax Biopharmaceuticals | 11.43B |
| Mabwell (Shanghai) Bioscience | 11.43B |
| InventisBio | 11.36B |
| Hualan Biological Vaccine | 11.00B |
| Nanjing Vazyme Biotech | 10.66B |
| Staidson (Beijing) BioPharmaceuticals | 10.21B |